Metered dose inhalers sales will expand through 2036, with preventive inhalers holding a 53.0% share in 2026 as the leading product type segment. Homecare leads the end user segment with a 58.0% share. The market is expected to reach USD 28.64 billion in 2026 and USD 44.48 billion by 2036.